This document aims to provide a guide for health workers who can participate in food aid for COVID-19 patients in intensive care. It`s about why, when, and how parenteral (PR) power can be used. Patients with COVID-19 infection often have symptoms of the gastrointestinal tract (including diarrhea/constipation) and the virus, detected in stool by about 50%, is excreted in the stool for an average of 11 days after clearance. A loss of taste, smell and loss of appetite occurs early in the disease and more serious problems of GI dysfunction that can impair absorption occur later in the disease. There are 2 types of patients: patients with primary INFECTION with COVID-19 and those with another disease (for example.B. postoperative, trauma, sepsis, etc.) and secondary infection with COVID-19. There are large national/international differences in the proportion of COVID-19 patients given PR (low prevalence in the UK). This may reflect access to naso-enteric tube insertion services (including the tubes themselves or pumps) and concern to increase the risk of venous thrombosis. This document assumes that all staff members are dressed in complete personal protective equipment (PPE). Home Parenteral Support (HPS) (including home parenteral feeding [PNH] and/or liquid) is the treatment of patients with type 3 (IF) bowel failure who need long-term support…